Screener
Lifecore Biomedical, Inc. LFCR Income Statement
| Q1 '27 | Q4 '26 | Q2 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| $34.17M— | $23.19M-36.4% | $31.11M-4.5% | $36.44M-3.8% | $35.15M-1.5% | ||
| $22.09M— | $18.73M-16.6% | $23.32M+8.6% | $22.46M+9.0% | $25.31M+6.3% | ||
| $12.08M— | $4.46M-68.1% | $7.79M-29.7% | $13.98M-19.0% | $9.85M-17.2% | ||
| 35.3%— | 19.2%-19.1pp | 25%-9.0pp | 38.4%-7.2pp | 28%-5.3pp | ||
| $1.54M— | $1.22M-42.1% | $1.96M+2.0% | $2.1M-2.7% | $2.05M-5.8% | ||
| $7.97M— | $7.92M-11.8% | $8.9M-20.0% | $8.98M-26.5% | $9.98M+1.3% | ||
| $2.57M— | -$4.67M-188% | -$3.07M-56.6% | $5.33M— | -$9.03M-909% | ||
| 7.5%— | -20.1%-34.8pp | -9.9%-3.8pp | 14.6%— | -25.7%-23.2pp | ||
| —— | —— | —— | —— | —— | ||
| $110K— | $110K-35.7% | $110K+136% | $171K+116% | $333K+141% | ||
| -$6.13M— | -$14.94M-1,241% | -$9.66M-47.9% | -$1.11M— | -$14.78M-199% | ||
| $23K— | $43K+30.3% | $333K+674% | $33K— | -$8K-104% | ||
| -$6.16M— | -$14.98M-1,206% | -$9.99M-52.0% | -$1.15M— | -$14.77M-194% | ||
| -18%— | -64.6%-61.4pp | -32.1%-11.9pp | -3.1%— | -42%-85.8pp | ||
| -$0.19— | -$0.43-617% | -$0.29-16.0% | -$0.06— | -$0.42-200% | ||
| $5.08M— | -$2.36M-133% | -$1.09M-1,378% | $7.24M— | -$6.95M-726% | ||
| 14.9%— | -10.2%-30.1pp | -3.5%-3.8pp | 19.9%— | -19.8%-22.9pp | ||
| $2.57M— | -$4.67M-188% | -$3.07M-56.6% | $5.33M— | -$9.03M-909% |
FAQ
- What are Lifecore Biomedical, Inc.'s profit margins?
- Gross margin is 31.3% and operating margin is -13.4%, with a -30.0% net margin.
- Where does Lifecore Biomedical, Inc.'s income statement data come from?
- Every line is extracted from Lifecore Biomedical, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.